Nuvation Bio Inc.
NUVB
$5.68
+1.25%
NUVB price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Nuvation Bio Inc.'s 12-month outlook, with a consensus price target around $7.38 and implied upside of +29.9% versus the current price.
Average Target
$7.38
3 analysts
Implied Upside
+29.9%
vs. current price
Analyst Count
3
covering this stock
Price Range
$5 - $7
Analyst target range
NUVB Technical Analysis
Beta
1.56
1.56x market volatility
Max Drawdown
-57.5%
Largest decline past year
52-Week Range
$2-$10
Price range past year
Annual Return
+191.3%
Cumulative gain past year
| Period | NUVB Return | S&P 500 |
|---|---|---|
| 1m | +18.8% | -1.3% |
| 3m | +25.9% | +14.0% |
| 6m | -36.6% | +9.5% |
| 1y | +191.3% | +20.9% |
| ytd | -33.8% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is NUVB Overvalued?
PE
-14.9x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-15.4x
Enterprise Value Multiple